Nath Bio-Genes (India) Ltd - 537291 - Board recommends Dividend
Nath Bio-Genes (India) Ltd has informed BSE that the Board of Directors of the Company at its meeting held on May 30, 2022, inter alia, has recommended dividend for financial year 2021-22 of Rs. 2/- (i.e. 20%) per equity shares of the nominal value of Rs. 10.00 per share fully paid up, subject to approval of shareholders in upcoming Annual General Meeting of the Company. Nath Bio-Genes (India) Ltd - 537291 - Board Meeting Outcome for The Outcome Of Board Meeting
Outcome of Board Meeting held on 30th May 2022. Nath Bio-Genes (India) Ltd - 537291 - Audited Financial Results As On 31St March 2022
Audited Financial Results as on 31st March 2022 Nath Bio-Genes (India) Ltd - 537291 - Intimation Of Conference Call To Be Held On 30Th May 2022
Intimation of Conference call to be held on 30th May 2022 Nath Bio-Genes (India) Ltd - 537291 - Board to consider Dividend
Nath Bio-Genes (India) Ltd has informed BSE that a meeting of the Board of Directors of the Company will be held on May 30, 2022, to approve the following:1. To consider, approve and take on record Audited Financial Results of the Company for the 4th quarter and year ended March 31, 2022.2. To consider recommendation of Dividend for the year 2021-22, if any subject to Approval of shareholders in ensuing AGM.3. To decide the date of Annual General Meeting of the Company.The Company has already closed its 'Trading Window' under the Code of Conduct for prevention of Insider Trading from March 31, 2022 and it will re-open on June 02, 2022. Nath Bio-Genes (India) Ltd - 537291 - Board Meeting Intimation for To Consider And Approve Audited Financial Results Of The Company For The Financial Year Ended 31St March 2022.
Nath Bio-Genes (India) Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 30/05/2022 ,inter alia, to consider and approve Audited financial results of the Company for the financial year ended 31st March 2022. Nath Bio-Genes (India) Ltd - 537291 - Compliances-Reg.24(A)-Annual Secretarial Compliance
Annual Secretarial Compliance Report Nath Bio-Genes (India) Ltd - 537291 - Compliances-Certificate under Reg. 74 (5) of SEBI (DP) Regulations, 2018
Compliance Certificate Under Reg 74(5) of SEBI (DP) Regulations Nath Bio-Genes (India) Ltd - 537291 - Compliance Certificate Under Reg 7(3).
Compliance Certificate under Reg 7(3).